Combined Pulmonary Fibrosis and Emphysema (CPFE) in a Never-Smoker
Imaging findings
CT chest demonstrates a combination of mild, upper-lobe-predominant paraseptal emphysema and a subpleural, basal-predominant UIP pattern of lung fibrosis with traction bronchiectasis. Over seven years of follow-up, there is significant progression of the subpleural fibrosis and traction bronchiectasis, alongside the development of marked tracheal dilation and corrugation resembling Mounier-Kuhn syndrome.
Key takeaways
Combined pulmonary fibrosis and emphysema is strongly associated with a history of heavy smoking. Finding both paraseptal emphysema and progressive UIP-like fibrosis in a lifetime never-smoker is highly unusual and should prompt a thorough evaluation for occult connective tissue diseases (such as rheumatoid arthritis) or alternate chronic exposures. Additionally, the progression of progressive lung fibrosis can be associated with tracheobronchomegaly and expiratory airway collapse.
AI-assisted summary — may contain errors. Verify against the source video. Learn more
More from this webinar
- Asian PanbronchiolitisInflammatory
- Fish Antigen Hypersensitivity PneumonitisILD
- Pacemaker Lead Displacement by Jugular CatheterIatrogenic
- Hyperthermia Treated with Ice PacksArtifact
- Ataxia-Telangiectasia with Progressive Bronchiectasis and Dendriform Pulmonary OssificationCongenital
- Asymmetric Pulmonary Edema from Mitral Valve RegurgitationVascular
- Partial Anomalous Pulmonary Venous Return (PAPVR) with Sinus Venosus ASDCongenital
- Pectus Carinatum Repair (Modified Ravitch Procedure)Congenital
See all cases from July 14, 2021 →
Related ILD cases
- Rheumatoid Arthritis-Associated Interstitial Lung Disease (UIP with Exuberant Honeycombing)
- Progressive Systemic Sclerosis with Pulmonary Ossification
- Anti-MDA5 and PL-7 Positive Amyopathic Dermatomyositis Presenting as Acute Lung Injury
- Atezolizumab-Induced Organizing Pneumonia
- Durvalumab-Induced Pneumonitis
- Reversible Smoking-Related Respiratory Bronchiolitis